Researchers find drug used widely to treat eye condition has 'no benefit'
Researchers from the University of Bristol and University Hospital Southampton have found that a drug used widely to treat a common eye condition has “ no benefit ” and should no longer be used.
Eplerenone, which is primarily used to treat heart failure, is currently offered widely by ophthalmologists as a treatment for central serous chorioretinopathy (CSCR) based on limited clinical data.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Research, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news
More News: Cardiology | Heart | Heart Failure | Hospitals | Opthalmology | Universities & Medical Training